ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Foghorn Therapeutics Inc

Foghorn Therapeutics Inc (FHTX)

8.01
-0.79
(-8.98%)
Closed 16 November 8:00AM
8.01
0.00
( 0.00% )
Pre Market: 11:00PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 6.63M4.18M5.31M5.6M17.48M5.77M5.05M6.89M
Operating Income -28.26M-31.89M-33.32M-32.05M-17.08M-30.78M-28.19M-26.63M
Pre Tax Income -25.77M-28.89M-29.93M-28.55M-13.61M-22.12M-25.02M-22.98M
Net Income -25.77M-28.89M-30.49M-29.49M-14.35M-24.11M-25.02M-22.98M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -28.26M-29.31M-32.6M-31.34M-16.36M-30.1M-27.46M-25.85M
EBITDA -27.42M-31.04M-32.46M-31.17M-16.22M-29.93M-27.36M-23.44M
Year End 31 December 2023 201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00430k1.32M19.23M34.16M
Operating Income -26.05M-51.08M-68.53M-100.73M-117.14M-107.91M
Pre Tax Income -26.34M-51.13M-68.8M-101.32M-108.88M-94.2M
Net Income -26.34M-51.13M-68.8M-101.32M-108.88M-98.43M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -4.097-5.674-1.87-2.453-2.605-2.331
EBIT -26.05M-51.08M-68.75M-101.97M-114.56M-105.08M
EBITDA -25.67M-50.39M-67.2M-97.51M-113.82M-104.46M